Roivant Sciences (ROIV) Net Margin Growth (1y) (2021 - 2024)
Roivant Sciences (ROIV) Net Margin Growth (1y) (2021 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,245.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,120.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Roivant Sciences |
21.82 Bn |
22.59 Bn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
400,082.00 |
| Sep 30, 2024 |
140,776.00 |
| Jun 30, 2024 |
263,117.00 |
| Dec 31, 2023 |
188,267.00 |
| Sep 30, 2023 |
15,021.00 |
| Jun 30, 2023 |
667,522.00 |
| Dec 31, 2022 |
-99,970.00 |
| Sep 30, 2022 |
-90,750.00 |
| Jun 30, 2022 |
-688,458.00 |
| Dec 31, 2021 |
353,550.00 |
| Sep 30, 2021 |
243,048.00 |
| Jun 30, 2021 |
-80,061.00 |
